Tn polyagglutinability syndrome is an acquired condition where erythrocytes express Tn neo-antigen and become susceptible t o hemagglutination by the naturally occurring anti-Tn present in normal sera. Early studies had indicated that 0-linked N-acetyl galactosamine was the sole serologic Tn determinant, but more recently 0-linked NeuNAcd, 6GalNAc also has been implicated as a Tn antigen (sialosyl-Tn). However, none of these studies were performed on purified glycoproteins. In this report we examine oligosaccharides of glycophorins A and B purified from Tn erythrocytes of two affected individuals t o establish how N-and 0-linked saccharides differ from normal. Analysis of carbohydrate composition and treatment with N-glycanase showed that the Asn-linked unit of glycophorin A was not affected. 0-linked oligosaccharides were obtained by @elimination in the presence of tritiated sodium borohydride. The reduced radiolabeled products were fractionated by Bio-Gel P-2 chromatography, and their structures were investigated by comparison with standards, by monosaccharide quantification, and by neuraminidases of known specificities. The results
show that Tn glycophorins from both donors contain intact and truncated forms of trisaccharide and tetrasaccharide NeuNAca2.3Galp1. 3GalNAc and NeuNAca2,3Galp1,3-(NeuNAcd.6)GalNAc usually present in glycophorins A and B. The truncated forms include the protein 0-linked monosaccharide, GalNAc and disaccharide, NeuNAcd.6GalNAc (major isomer). The presence of intact glycans in the total population of Tn erythrocytes was confirmed by their susceptibility to T activation after treatment with neuraminidase. The proportion of the four species was not identical in glycophorins of these two donors but, in both, the truncated units predominated and the amount of the disaccharide was approximately one half of that of the monosaccharide. The data are consistent with alterations in UDPGal: GalNAcpl.3galactosyl transferase that may have multiple molecular origins and with induction of a specific GalNAc protein d . 6 sialosyl transferase in Tn hematopoietic precursor cells. The molecular basis for these alterations awaits further study. o 1992 by The American Society of Hematology. be deficient in this e n~y m e .~J~ The clonal origin of Tn antigen was demonstrated, and its expression was shown to occur at very early stages of differentiati~n.~.'~ It was proposed that development of Tn antigen was the direct consequence of an alteration in the GalNAcpl,3Gal transferase that occurred in stem cells of hematopoietic tissue; this resulted in incomplete biosynthesis of 0-linked oligosaccharides of membrane glycoproteins.2-8J2
More recently Kjeldsen et all5 showed that a monoclonal antibody (MoAb) specific for NeuNAcol2,6GalNAc, agglutinated Tn erythrocytes. This indicated that in addition to GalNAc, this disaccharide also is present on Tn-positive cells and could be a Tn determinant (sialosyl Tn); however, the structural basis for this conclusion has not been obtained so far. Both antigens are widely distributed on malignant tumor cells but are rarely detected in normal tis~ues.'~J' They are recognized as tumor-associated antigens and their abundance on cell surfaces may be prognostic of tumor aggressiveness and metastatic potential. 16-ls The Tn syndrome is usually a persistent condition, but it may be transient in some cases. Clearly, more than a single pluripotent stem cell may be affected, and the abnormal clone may disappear spontaneously or as a result of cytotoxic therapy.1y,20
Because structures of the 0-linked glycans thus far have not been directly analyzed in purified Tn-glycoproteins, here we examined these structures in glycophorins A and B (designated here, Tn glycophorins A and B) isolated from erythrocytes of two unrelated individuals affected with the Tn syndrome. Glycophorins A and B are the most abundant glycoproteins of the human erythrocyte membrane and carry the antigenic determinants for MNSs blood groups.2' Carbohydrates constitute 60% of these glycoproteins and are distributed between a single Asn-linked complex unit and about 14 0-linked trisaccharides, tetrasaccharides, and pentasaccharides (see Table 3 for structures), all clustered at the amino-terminal extracellular d~m a i n .~~-~~ We show here that in Tn glycophorins, both intact and truncated forms of the usual 0-linked tetrasaccharide and trisaccharide are present. We also show that the relative abundance of these carbohydrate units is significantly different in Tn glycophorins of the two individuals, suggesting that alterations in the glycosyl transferase may have multiple molecular origins.
EXPERIMENTAL PROCEDURES

Blood Samples
Erythrocytes from two patients with persistent Tn-polyagglutinability syndrome were studied. The first patient (D.J.H.) had a 20-year history of severe thrombocytopenia and leukopenia complicated by intermittent urinary bleeding, stomatitis, and chronic gingivitis. Diagnosis of polyagglutinability syndrome was not made until 1988 when it was found that greater than 95% of the patient's erythrocytes were agglutinated by normal sera, and the diagnosis was subsequently confirmed by reaction with an anti-Tn MoAb. The second patient (C.C.) was diagnosed as having red blood cell polyagglutinability in 1968, during a gall bladder surgery. He was asymptomatic and had maintained normal leukocyte and erythrocyte counts, but his platelet count ranged between 40,000 and 50,000/mm3. Nearly 100% of this patient's erythrocytes were polyagglutinable.
Fresh packed cells, 115 mL, were obtained from C.C. and about 20 mL from D.J.H. Erythrocytes from 1 U of blood from a person with normal counts were collected to serve as a control. Serologic typing showed the following: C.C.: B+, M-, N+, S-, s+, Tn+; D.J.H.: B+, M+, N-, S-, s+, Tn+; control: B+, M-, N+, S-, s+, Tn-. Two milliliters of 4% suspensions of washed erythrocytes from patient C.C. and from a control, blood group B donor were incubated at 37°C for 60 minutes with 0.05 mL vibrio cholera neuraminidase (Behring Diagnostics, Summerville, NJ). Desialosylation was confirmed by loss of reactivity of the control cells with Polybrene (Aldrich Chemicals, Milwaukee, WI). The source of anti-T was a normal serum that was exhaustively absorbed in the cold with both Tn and control erythrocytes to remove anti-Tn and the naturally occurring cold agglutinins.
Isolatwn of glycophorins A and B from Tn erythrocytes.
Erythrocyte membranes were prepared and glycophorins isolated by either the pyridine-ethanol procedure or sodium dodecyl sulfatetrichloroacetic acid (SDS-TCA) fractionation with or without prior phenol-urea extracti~n.~~.~' In the majority of experiments, SDS-TCA fractionation was conducted without prior phenol-urea extractions.
SDS-10% polyacylamide gel electrophoresis (SDS-PAGE) and immunoblotting.
The procedure of LaemmliB was used for electrophoresis of erythrocyte lysates and isolated glycophorins. Gels were stained with Coomassie Blue and Periodic Acid-Schiff reagent (Schiff) or subjected to immunoblotting. A glycophorin polyclonal antiserum, M-and N-specific M0Abs,2~ and anti-Tn and anti-GalNAc MoAbs (see below) were used as reagent probes. Protein bands were visualized by reaction with 1251-labeled Protein A followed by autoradiography.
Glycophorins were treated with N-glycanase (peptide-N4[Nacetyl-fi-glucosaminy1] asparagine amidase) (Genzyme, Boston, MA) as specified by the manufacturer. They were then subjected to SDS-PAGE and the bands were visualized by immunoblottingJ6 Erythrocytes for immunization were obtained from a patient with polyagglutinability syndrome (for anti-Tn) or from a normal group A blood
Neuraminidase treatment of eythrocytes for T activation.
Preparation of anti-Tn and anti-GalNAc MoAbs.
donor (for anti-GalNAc). The cells were washed three times, and lo7 cells were injected intraperitoneally into Balb/c mice without any adjuvant. A second dose was injected intravenously 10 days later. The immunized mice were killed 3 days later and their spleens removed aseptically. Spleen cell suspensions were fused with NS-1 myeloma cells?0 Colonies were screened 10 days later and their supernatants tested in an agglutination assay against normal, Tn, or A cells. The colonies producing anti-Tn or anti-GalNAc antibody were then cloned using a limited dilution technique. This procedure was repeated twice and the final clones were grown in culture; their collected supernatants were used in this study. Specificity of anti-GalNAc was established by its reactivity with blood group Al (but not A2 erythrocytes), a reaction which unlike anti-Al was completely blocked by the addition of free GalNAc.
Treatment with NaOH-tritiated sodium borohydride and isolation of 0-linked oligosaccharides on Bio-Gel P-2. Previously The pH was lowered to 4 to 5 by addition of about 1.5 mL methanolic-acetic acid, and excess tritiated water and borate were removed by evaporation under vacuum in an Evapomix (Buchler Instruments, Fort Lee, NJ). This was followed by at least four washes with methanoL3* For removal of peptides and free amino acids, the residue was dissolved in about 1 mL 0.001 mol/L HCOOH and passed through a 9-g column of Dowex 50 (Bio-Rad, Richmond, CA) (1 cm x 4 cm) equilibrated and eluted with 0.001 mol/LHCOOH. The eluate was lyophilized. A portion was used for carbohydrate analysis and the rest subjected to gel filtration on a calibrated Bio-Gel P-2 (Bio-Rad) column (1.4 cm x 140 cm); 0.1 mol/L pyridine acetate buffer pH 5.0 was used at a rate of 4.5 mL/h.31 Standards for calibration were as previously described.31 Approximately 120 fractions of 1.8 mL each were collected and radioactivity determined. Fractions in each peak were pooled and lyophilized.
Characterization of 0-linked oligosaccharides. Chromatography on a Dionex Bio-LC high-performance anion-exchange system equipped with a Dionex CarboPac PA-I strongly basic anionexchange column (4 X 250 mm) and pulsed amperometric detection unit (model IIPAD detector) (HPAE-PAD)33 was used. The elution position of material in each peak before and after desialosylation were compared with those of known standard compounds and oligosaccharides of control glycophorins?' In some experiments the elution profile was also determined by radioactivity in 1-mL fractions collected at a rate of 1 mL/min. The following eluants were used: 14 mmol/L NaOH as eluant 1, 100 mmol/L NaOH as eluant 2, and 0.5 N sodium acetate in 100 mmol/L NaOH as eluant 3. The flow rate was 1 mL/min. The program used to elute the oligosaccharides was as follows: (1) 100% eluant 1 for 20 minutes; (2) a linear gradient to 100% eluant 2 over the next 5 minutes followed by elution for 10 minutes at 100% eluant 2; (3) a linear gradient from 100% eluant 2 to 30% eluant 3 over the next 40 minutes; (4) a linear gradient, from 30% to 100% eluant 3 over 5 minutes followed by elution for 10 minutes with 100% eluant 3. The column was washed with 0.5N NaOH 2 for 10 minutes and re-equilibrated to the initial conditions with eluant 1.
Monosaccharide analysis and quantitation of oligosaccharides. For quantification of hexoses and hexosamines, samples were treated with 2 mol/L trifluoroacetic acid (TFA) at 100°C for 4 hours34; for measurement of NeuNAc, hydrolysis in 0.05N HCI at 80°C for 30 minutes was used. Excess TFA or HCI was removed under vacuum in a Speed Vac Concentrator (Savant Instruments, Inc, Farmingdale, NY) and the monosaccharides were quantified For personal use only. on October 22, 2017. by guest www.bloodjournal.org From on the Dionex instrument using either step 1 of the elution program or the gradient described above. Deoxyglucose and I-phosphoglucosamine were used as internal standards.
Radioactivity in reduced galactosaminintol (13H]GalNOH) was quantified on a Beckman 6 3 0 amino acid analyzer (Beckman Instrument Co, Fullerton, CA) equipped with a split stream device. Contents of GalNOH were estimated from the specific activity of [3H]GalNOH obtained by hydrolysis of the tetrasaccharide isolated from a control glycophorin treated with NaOH-[3H]NaBH4 in parallel with Tn glycophorins andlor [3H]GalNOH isolated from tetrasaccharides of Tn glycophorins.
The relative quantities of the oligosaccharides in the two Tn glycophorins were determined from radioactivity of [3H]GalNOH isolated from oligosaccharides in the Bio-Gel P-2 peaks.
DiResiion wiih neitraminidases and ana!ysis of proditcis. Newcastle disease virus neuraminidase was purchased from Oxford Glyco-Systems lnc (Rosedale, NY). The enzyme is specific for a2.3 linked NeuNAc,35 but the preparation used contained a small amount of a2,h-activity as determined by the manufacturer from the rate of release of sialic acid from a2,6 sialosyl lactose (rate of release was < 2.4% of that from a2.3 sialosyl lactose: also see Fig 3) . Aliquots (55.000 to 75,000 cpm) of Bio-Gel P2 peaks a and c from donor C.C. were treated with 2.5 io 10 mU of enzyme in 0.1 mL 0.05 mollL sodium acetate buffer pH 5.5 for about 20 hours at 3PC. Contents of each incubation vial were then chromatographed on the calibrated Bio-Gel P-2 column under conditions specified above. The positions of elution of products were compared with those of control samples incubated as described above but lacking the enzyme.
Similar aliquotsof peaks a and c were also treated with 50 mU of C/o.siridiiim pfringens neuraminidase (type X: Sigma Chemical Co, St Louis. MO) in 0.25 mL of 0.1 mollL potassium acetate buffer pH 4.5 for 20 hours at 37°C. and analyzed as above on Bio-Gel P2.
RESULTS
!"pedes of Tn Glycophorins
Glycophorins A and B could bc isolated in purc form from Tn crythrocytcs by cithcr pyridinc-cthanol fractionation or SDS-TCA extraction with or without prior phcnolurca trcatmcnt. Thc Tn and control glycophorins had a similar ovcrall appcarancc on SDS-PAGE, cxccpt for a slightly fastcr migration of Tn glycophorin A dimer and a dccrcascd staining by Schiff rcagcnt (Fig 1A) .
Tn glycophorins A and B could be visualizcd on immunoblots ( Fig 1B) . Thc formcr rcactcd with M-or N-spccific MoAbs in accord with results of their scrologic typing, exccpt for a faint but positivc signal with the N-spccific MoAb of the Tn glycophorin A of D.J.H., whose erythrocytcs wcrc N-ncgativc. That diffcrcnt rcsponse may be caused by an inhcrcnt diffcrencc bctwccn thc polyclonal antiscrum used for typing and thc MoAb, or by a diffcrencc in thc sensitivity of thc two assay systems used. The Tn glycophorin B of both donors rcactcd with the N-spccific MoAb (this is thc expcctcd rcaction of normal glycophorin B)." Positivc reactions with the M-and N-specific rcagents suggest that a normal glycosylation pattern cxists at the amino-tcrmini of thc Tn glycophorins whcrc the cpitopcs for thcsc antibodies rcsidc.fh
In contrast to control glycophorins, thc Tn glycophorins rcactcd with anti-Tn and anti-GalNAc MoAbs. This finding indicated that carbohydratc epitopcs, abscnt in control glycophorins, including 0-linkcd GalNAc, bccamc cxposcd in Tn glycophorins (Fig IB) . Thc possiblc prcscncc of both intact and truncated 0-linked oligosaccharidcs was also indicated by the overall carbohydrate composition of Tn glycophorins and, in particular, by thc dccrcascd lcvcls of Gal and NeuNAc, whose magnitude diffcrcd bctween the two donors (Tablc 1) (see bclow). Rclativc amounts of GlcNAc and Man also indicated that thc singlc Asn-linked complex carbohydrate unit, usually prcscnt in control glycophorin A,' ? was also prcscnt in Tn glycophorins. This was confirmed by trcatmcnt with N-glycanasc, which rcsultcd in an increascd mobility of the Tn glycophorin A band idcntical to that obscrvcd with a similarly trcatcd glycophorin A control (Fig IC) .
Isolation and Characterization of 0-Linked Oligosaccharides of Tn Glycophorins
Tn and control glycophorins wcrc subjcctcd to p-elimination in thc prcscncc of ["]NaBH.,, and thc oligosaccharidc products containing a tritium-labeled reduced GalNAc ([3H]GalNAcOH) were chromatographed on Bio-Gel P-2. The elution patterns of glycophorins from both donors are shown in Fig 2. In the control, peaks a and b correspond to the tetrasaccharides and trisaccharides usually present in glycophorins A and B23,31; the pentasaccharides, also present in control glycophorin~,~~ were not investigated here because of their relatively low amounts (for structures see Table 3 ). In Tn glycophorins, peaks at positions parallel to a and b are also present, in addition to two major peaks c and d; the latter peaks are absent in the control (see below and Table 2 ). The overall pattern and, in particular, the relative abundance of the four peaks are not identical in glycophorins of both donors (Fig 2) .
Oligosaccharides in Bio-Gel P-2 peaks a to d were chromatographed on HPAE-PAD. The mobility of peaks a and b from both Tn glycophorins corresponded to the position of elution of control tetrasaccharide and trisaccharide, respectively, and the material in peak d eluted at the beginning of the elution program (2.6 minutes), corresponding to standard GalNAcOH. Desialosylation of control peaks a and b and Tn glycophorins peaks a -+ c resulted in the appearance of radiolabeled saccharides that emerged at similar positions (2.6 minutes + 3.1 minutes) and in a corresponding release of NeuNAc (data not shown).
Quantification of Monosaccharides in Bio-Gel P-2 Peaks a -z d
The kind and quantity of monosaccharides in Bio-Gel P-2 peaks a + d from Tn and control glycophorins are shown in Table 2 . The molar ratios indicate that in Tn glycophorins from both donors peak a is the tetrasaccharide and peak b the trisaccharide, most probably of structures identical to those present in control glycophorins (Table 3) . This was consistent with the chromatographic behavior of these saccharides on Bio-Gel P-2 and HPAE-PAD chromatography before and after desialosylation.
Peak c of Tn glycophorins contained nearly equal molecular amounts of NeuNAc and [3H]GalNOH and virtually lacked Gal. This indicates that the material in peak c is a disaccharide, whose structure could be NeuNAcd,6GalNAc and/or NeuNAca2,S GalNAc, the sialosylated form of the 0-linked GalNAc, the reported determinant of the Tn phenotype.
In peak d the presence of GalNOH (after TFA hydrolysis) in radiolabeled form and the absence of Gal and NeuNAc or other usual monosaccharides indicated that this peak originated from 0-linked GalNAc (Table 2) . This was consistent with its comigration in its acylated form with the standard on Bio-Gel P-2 and HPAE-PAD and, following acid hydrolysis, as [3H]GalNOH on the column of the amino acid analyzer.
Peaks eluting at about 175 and 185 mL (Fig 2) contained no [3H]GalNOH and were probably residual salts or 3H20 from the [3H]NaBH4 reduction.
The composition of Bio-Gel P-2 peaks a and b from control glycophorin verified that they contained the expected tetrasaccharide and trisaccharide; the other radiolabeled Bio-Gel P-2 peaks (Fig 2) contained no [3H]GalNOH and therefore were not 0-linked derived structures. The absence of truncated 0-linked saccharides in the control glycophorin is in agreement with previous analyses by and with the observation that the control glycophorin failed to react with anti-GalNAc and anti-Tn MoAbs (Fig 1B) .
Linkage of NeuNAc to GalNAc in the disaccharide in Bio-Gel P2peak c. To establish the linkage of NeuNAc to
GalNAc in the disaccharide in Bio-Gel P-2 peak c, a2,3specific Newcastle disease virus ne~raminidase~~ was used and the course of digestion of the disaccharide was compared with the digestion of the tetrasaccharide in peak a (NeuNAca2,3Gal p 1,3( NeuNAca2,6)GalNAcOH). Digestion with Clostridium perfnngens neuraminidase3' was used as control ( Fig 3) . As expected, the latter enzyme released Galpl,3[3H]GalNAcOH from the tetrasaccharide in peak a Table 3 and [3H]GalNAcOH from the disaccharide in peak c ( Figs  3B and C, respectively) .
. Structures of Oligosaccharides in Tn (a through d) and Control (a and b) Glycophorins
Also, as expected, the digestion of the tetrasaccharide with a2,3-specific Newcastle disease virus neuraminidase resulted in its conversion to the trisaccharide ( Fig 3D) ; with identical concentrations of that enzyme the radioactivity in the disaccharide in peak c was essentially unaffected ( Fig  3E; insets Fig 3, D and E) . All of the radioactivity of the tetrasaccharide and the disaccharide incubated under identical conditions, but without enzymes were recovered in peaks a and c exclusively ( Fig 3A) . Together, the data indicate that the disaccharide N~UNAC[~H]G~INACOH in peak c is predominantly in the form of the d,6-linked isomer. This is in agreement with the immunochemical data of others.I5
Relative Quantities of Oligosaccharides in Tn Glycophorins From the Two Donors' Eiythrocytes
Bio-Gel P-2 patterns first suggested that the relative amounts of the four species of 0-linked oligosaccharides were not identical in the two Tn glycophorins (Fig 2) . Because GalNAc is the terminal carbohydrate in these oligosaccharides, their ratios could be quantified from the relative ratios of radioactivity associated with isolated [3H]GalNOH after hydrolysis of material in each Bio-Gel P-2 peak. As shown in Table 4 , Tn glycophorin from D.J.H., compared with Tn glycophorin from C.C., contains more than twice the amounts of the usual tetrasaccharides and trisaccharides; yet the ratio of GalNAc to that of the disaccharide is the same in both Tn glycophorins; that indicates that the level of sialosylation of free 0-linked GalNAc is similar in both donors.
After treatment with nbrio cholera neuraminidase, erythrocytes from control and the Tn donor reacted with anti-T; the reaction was markedly enhanced by cold incubation without any free cells being observed microscopically. This indicated that all Tn cells had become T-activated. To quantify this process, the ability of T-activated Tn cells to absorb anti-T was compared with that of control cells, and was found to be approximately 10% (data not shown). preparative yields and a Schiff-positive reaction on PAGE first indicated that Tn glycophorins contain significant quantities of NeuNAc.
T-activation of Tn cells.
Reaction with N-glycanase and the relative quantities of GlcNAc and Man indicated that Tn glycophorin A contained the usual single complex Asn-linked unit.22 This suggested, in agreement with data of others,12 that the GlcNAcp1,4 Gal transferase and other glycosyl transferases participating in the biosynthesis of the complex oligosaccharide were not affected in the Tn cells of these two donors.
Carbohydrate analysis indicated that in addition to usual monosaccharides, glycophorins from both individuals contained Gal and NeuNAc, but in reduced amounts when compared with controls. Several lines of evidence then indicated that the major 0-linked glycans present in glycophorins A and B of normal individuals are present in Tn glycophorins in both intact and truncated forms. The latter include 0-linked GalNAc and its sialosylated disaccharide, NeuNAca2,6GalNAc. Their identification verified previous data on Tn erythrocyte glycopeptides" and provided a structural basis for previous immunologic observation^.^^ The finding of NeuNAca2,6GalNAc in Tn glycophorins is unexpected because previous reports suggest that the transferase that introduces a NeuNAc residue in an a2,6 linkage directly to the protein-linked GaINAc is present predominantly in tissues engaged in mucin p r o d~c t i o n .~~?~~ That this GalNAc protein a2,6 sialosyl transferase is not normally present in hematopoietic cells is further suggested by the consistent absence of the disaccharide in normal g l y~o p h o r i n s~~,~~,~~ (and this report). Thus, although evidence is indirect, our data suggest that this enzyme may become induced in Tn abnormality. In addition, the same 1:2 ratio of the truncated disaccharide to the monosaccharide found in both Tn glycophorins indicates that the activity of this transferase is comparable in the cells of both donors and, in each, results in sialosylation of approximately one third of the available acceptor substrate group, Ser/Thr 0-linked GalNAc ( Table 4 ).
Because NeuNAca2,6GalNAc is a poor substrate for GalNAcp1,3 Gal transferase$O premature sialosylation of GalNAc could be the major cause of the incomplete For personal use only. on October 22, 2017. by guest www.bloodjournal.org From synthesis of 0-glycans in the Tn syndrome; this presumption is excluded on the basis of the presence in both Tn glycophorins of relatively large amounts of free, unsialosylated 0-linked GalNAc. Rather, the data support the previous conclusion that the Tn syndrome may arise from an alteration in GalNAcpl,3Gal transferase for which the protein Ser-or Thr-0-linked GalNAc serves as a substrate acceptor in the biosynthetic assembly of 0-linked glycans.
The presence of smaller but significant amounts of the usual tetrasaccharide and trisaccharide in Tn glycophorins excludes compartmentalization of the glycosyltransferases as the cause of the variation. Instead, it suggests that the GalNAcpl,3Gal transferase may not be totally lacking in the cells of individuals we studied; more likely the enzyme is present but is less active. This would result in a failure to introduce Gal at all the potentially available GalNAc sites. The sequential assembly of those units where Gal was introduced would then proceed to completion whereas the units lacking Gal would remain truncated.
This situation may be analogous to that occurring in human T-leukemia Jurkat cell line where a defect, but not a total absence, in the same transferase was proposed to be responsible for the occurrence of truncated 0-linked units, in the form of 0-linked GalNAc. It was observed that the major surface glycoprotein of Jurkat cells, leukosialin, contains in addition to the truncated 0-linked GalNAc, small amounts of intact trisaccharide and However, it is noteworthy that Jurkat cells lack the disaccharide NeuNAccu2,6GalNAc, reinforcing our observation of the presence of a unique sialosyl transferase in Tn cells.
It should be noted that the intact and truncated glycans in Tn glycophorins studied here occur on the same erythrocytes. This is evidenced by the fact that the population of Tn-positive cells was close to 95% in both individuals and therefore the relative concentrations found for the intact structures far exceeded the amount that may have been derived from the insignificant number of normal cells present. In fact, the proportion of normal erythrocytes in these two samples, especially those of patient C.C., was so small that we felt no need to purify the Tn cells before isolation of glycophorins. In addition, the demonstration of the susceptibility of the Tn cells to T-activation provided strong supportive evidence for the conclusion that all of the Tn-positive cells carried intact 0-linked glycans.
Although aberrations in regulation or processing cannot be totally excluded, our observations are consistent with a mutation in Tn hematopoietic precursor cell or cells resulting in a structurally altered GalNAcp1,3 Gal transferase that exhibits a reduced enzymatic activity. Because the levels of intact trisaccharide and tetrasaccharide in the two Tn glycophorins differ significantly, the alteration in the GalNAcpl,3Gal transferase may not be identical in the cells of the two donors. Clearly, the nature of the molecular defect must await structural analysis of the GalNAcpl,3Gal transferase gene and of its processing. Of interest is the fact that the mutation in the transferase may occur in a hematopoietic pluripotent stem cell or in precursor cells in erythroid and other lineages at any stage of determination or differentiation. This is suggested by the profile of Tn-positive blood cells in different individuals affected with the Tn syndrome. 8 The availability of specific antisera and of carbohydratedirected MoAbs that specifically recognize the Tn (Gal-N A c )~* ,~~ and sialosyl-Tn (Ne~NAccu2,6GalNAc)~* antigens has allowed the detection of these structures on surfaces of a variety of human cancer cells.16-1s These antigens are particularly abundant on malignant colorectal tissues. Their patterns of expression seem to parallel those observed here for a single membrane glycoprotein, namely they have very restricted distribution in normal tissues but are coexpressed on malignant cells." Alterations in glycosylation patterns of cell surface glycolipids and glycoproteins have been shown often to accompany malignant tran~formation,4~.~~ and the ubiquitous appearance of Tn and sialosyl Tn antigens provided evidence that incomplete synthesis, probably caused by alterations in glycosyltransferases, including GalNAcp1,3 Gal transferase, may occur frequently in cancer cells.
Two perplexing aspects of the Tn syndrome deserve notice. First, the clonal origin of the Tn erythrocytessJ4 provides a potential for the entire cohort to be converted to the Tn form. Second, the different course taken in different affected individuals; this includes the expression of Tn phenotype on other lineages of blood cells and its association with malignant transformation of those cell~.~.S It is of interest that the health status of the two individuals we studied differed significantly: donor D.J.H. suffered from severe and symptomatic thrombocytopenia and neutropenia; donor C.C. was asymptomatic and had only a moderate thrombocytopenia. Unexpectedly, the glycosylation pattern appeared less normal in Tn glycophorins of C.C., while the pattern of D.J.H.'s Tn glycophorin showed higher relative abundance of the usual intact tetrasaccharide and trisaccharide. The significance of these findings and the molecular basis for the Tn condition are under study.
